Managers / Q4 2020 · view latest →
Zebra Capital Management LLC
CIK 0001316915 · 2187 ATLANTIC STREET, 4TH FLOOR, STAMFORD, CT, 06902 · 2038783223
Summary
Zebra Capital Management LLC reported $79M in U.S.-listed holdings across 163 positions for Q4 2020.
Its largest position, WDFC, represents 1.9% of the portfolio.
Compared with Q3 2020, the fund opened 5 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.4% · $70M
- Other · 6.1% · $5M
- REIT · 5.5% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TVTXRETROPHIN INC | NEW | +44.0K | 44.0K | +$1M | $1M |
| UEICUNIVERSAL ELECTRONICS INC COM | NEW | +5.3K | 5.3K | +$276,000 | $276,000 |
| HIBBETT SPORTING GOODS INC COM | NEW | +5.9K | 5.9K | +$273,000 | $273,000 |
| CALXCALIX INC | NEW | +8.9K | 8.9K | +$265,000 | $265,000 |
| SSTISILICON STORAGE TECHNOLOGY INC | NEW | +6.1K | 6.1K | +$232,000 | $232,000 |
| RETROPHIN INC | SOLD OUT | −39.8K | 0 | −$735,000 | $0 |
| BIOSPECIFICS TECHNOLOGIES | SOLD OUT | −8.9K | 0 | −$469,000 | $0 |
| COLLECTORS UNIVERSE INC COM ST | SOLD OUT | −5.9K | 0 | −$290,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2023 | $20M | 65 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $29M | 67 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $26M | 81 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $34M | 98 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $44M | 116 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $63M | 155 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $83M | 182 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $85M | 160 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $91M | 169 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $79M | 163 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $65M | 167 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $69M | 217 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $62M | 226 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $113M | 292 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $92M | 230 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $193M | 452 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $188M | 429 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $162M | 376 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.